Cyclophosphamide and ifosfamide: role of uroprotective agents.
Williams
S D
SD
Indiana University, Indianapolis.
Munshi
N
N
Einhorn
L H
LH
Loehrer
P J
PJ
D000111:Acetylcysteine / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects*; D006417:Hematuria / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage / Q000009:adverse effects*; D008623:Mercaptoethanol / Q000031:analogs & derivatives*; D015080:Mesna / Q000627:therapeutic use*; D014565:Urogenital Neoplasms / Q000188:drug therapy
D008623:Mercaptoethanol; D003520:Cyclophosphamide; D015080:Mesna; D007069:Ifosfamide; D000111:Acetylcysteine